D-1074-2019 Class II Terminated
FDA drug recall D-1074-2019 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Mar 29, 2019 and is designated Class II. Reason for recall: Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets. The recall status is terminated (terminated Sep 20, 2019). Affected quantity: 12,960 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 10, 2019
- Initiation Date
- Mar 29, 2019
- Termination Date
- Sep 20, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12,960 bottles
Product description
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.
Reason for recall
Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.
Distribution pattern
Nationwide in the USA.
Code information
Lot #: PA217060A, Exp 05/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1074-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026